Efficiency of a Pneumococcal Opsonophagocytic Killing Assay Improved by Multiplexing and by Coloring Colonies

ABSTRACT For evaluating pneumococcal vaccines, the opsonophagocytic killing assay (OPKA) is useful as a supplement to the pneumococcal antibody enzyme-linked immunosorbent assay (ELISA). However, evaluations of pneumococcal vaccines require the determination of antibody responses to 7 to 11 serotypes, and the OPKA is tedious to perform and requires more serum than the ELISA. Consequently, the OPKA is infrequently used for evaluating pneumococcal vaccines. To overcome these limitations, we have developed a simple multiplexed (double-serotype) OPKA by using antibiotic-resistant pneumococci for nine serotypes. Serotype 6B, 9V, 19A, and 23F strains were made streptomycin resistant, and serotype 4, 6A, 14, 18C, and 19F strains were made optochin resistant. The multiplexed OPKA was the same as the single-serotype OPKA except for two changes. First, the target bacteria were a mixture of one streptomycin-resistant strain and one optochin-resistant strain. Second, the surviving bacteria of each serotype were enumerated by plating on Todd-Hewitt agar plates with yeast extract and an agar overlay containing the appropriate antibiotics and 2,3,5-triphenyl tetrazolium chloride. The performance of the multiplexed OPKA was evaluated by analyzing 28 serum samples from adults immunized with a 23-valent polysaccharide vaccine by using the single-serotype OPKA and the multiplexed OPKA. The multiplexed OPKA was specific for the desired serotypes. The multiplexed and conventional OPKAs had comparable assay sensitivities and produced results that were highly correlated (r2 values ranging from 0.92 to 0.98) for all nine serotypes. A simple modification of the conventional OPKA produces a multiplexed assay that greatly reduces effort, reagents, and the necessary amount of serum.

[1]  M. Lipsitch.  Interpreting results from trials of pneumococcal conjugate vaccines: a statistical test for detecting vaccine-induced increases in carriage of nonvaccine serotypes. , 2000, American journal of epidemiology.

[2]  S. Finegold,et al.  Antimicrobial susceptibility testing of Bilophila wadsworthia by using triphenyltetrazolium chloride to facilitate endpoint determination , 1992, Antimicrobial Agents and Chemotherapy.

[3]  M. Nahm,et al.  Comparison of a Classical Phagocytosis Assay and a Flow Cytometry Assay for Assessment of the Phagocytic Capacity of Sera from Adults Vaccinated with a Pneumococcal Conjugate Vaccine , 2001, Clinical Diagnostic Laboratory Immunology.

[4]  N. Yamaguchi,et al.  Rapid enumeration of physiologically active bacteria in purified water used in the pharmaceutical manufacturing process , 1999, Journal of applied microbiology.

[5]  M. Koskela.  Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination , 1987, The Pediatric infectious disease journal.

[6]  J. C. Parke,et al.  Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. , 1983, The Journal of infectious diseases.

[7]  G. Siber,et al.  Standardization of antibody assays for measuring the response to pneumococcal infection and immunization , 1989, The Pediatric infectious disease journal.

[8]  M. Rennels,et al.  Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States Infants , 1998, Pediatrics.

[9]  C. Frasch,et al.  Pneumococcal Type 22F Polysaccharide Absorption Improves the Specificity of a Pneumococcal-Polysaccharide Enzyme-Linked Immunosorbent Assay , 2001, Clinical Diagnostic Laboratory Immunology.

[10]  P. Newburger,et al.  Laminin promotes differentiation of NB4 promyelocytic leukemia cells with all-trans retinoic acid. , 1996, Blood.

[11]  Y. Van Laethem.  [Pneumococcal polysaccharide vaccine]. , 2004, Revue medicale de Bruxelles.

[12]  I. Jónsdóttir,et al.  Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae. , 1994, The Journal of infectious diseases.

[13]  T. Menon,et al.  Disc diffusion test in the identification of Candida species , 2000, Mycoses.

[14]  J. Rubins,et al.  Determination of Antibody Responses of Elderly Adults to All 23 Capsular Polysaccharides after Pneumococcal Vaccination , 1999, Infection and Immunity.

[15]  M. Cetron,et al.  Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. , 2000, The New England journal of medicine.

[16]  J. Line,et al.  Development of a selective differential agar for isolation and enumeration of Campylobacter spp. , 2001, Journal of food protection.

[17]  M. Pichichero,et al.  Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults , 1997, Infection and immunity.

[18]  L. Devriese,et al.  Enumeration by a miniaturized method of Escherichia coli, Streptococcus bovis and enterococci as indicators of the origin of faecal pollution of waters. , 1991, The Journal of applied bacteriology.

[19]  S. Szu,et al.  Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods. , 1990, Microbial pathogenesis.

[20]  J. Whitin,et al.  Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells , 1997, Clinical and diagnostic laboratory immunology.

[21]  G. Carlone,et al.  Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group , 1997, Clinical and diagnostic laboratory immunology.

[22]  D. Goldblatt,et al.  A Flow Cytometric Opsonophagocytic Assay for Measurement of Functional Antibodies Elicited after Vaccination with the 23-Valent Pneumococcal Polysaccharide Vaccine , 1999, Clinical Diagnostic Laboratory Immunology.

[23]  S. Halperin,et al.  Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study. , 2002, Clinical and investigative medicine. Medecine clinique et experimentale.

[24]  P. Coudron,et al.  Tetrazolium reduction as an aid for streptococcal growth detection with agar dilution susceptibility testing , 1983, Journal of Clinical Microbiology.

[25]  Y. Vanlaethem.  Pneumococcal polysaccharide vaccine. , 2004, MMWR. Morbidity and mortality weekly report.

[26]  D. L. Klein,et al.  Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. , 1998, Vaccine.

[27]  E. Lewis,et al.  Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children , 2000, The Pediatric infectious disease journal.

[28]  J. Klein.  Pneumococcal otitis media vaccine trials , 1989, The Pediatric infectious disease journal.

[29]  R. Steele.  Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States Infants , 1998, Clinical pediatrics.

[30]  D. Briles,et al.  Development of a multi-specificity opsonophagocytic killing assay. , 2000, Vaccine.

[31]  D. Musher,et al.  Natural and vaccine-related immunity to Streptococcus pneumoniae. , 1986, The Journal of infectious diseases.